Teladoc price target lowered to $7 from $12 at Oppenheimer

Oppenheimer lowered the firm’s price target on Teladoc (TDOC) to $7 from $12 and keeps an Outperform rating on the shares. The firm notes Teladoc reported better than expected Q4 results, with adjusted EBITDA of $83.8M and revenues of $642M. The company also issued 2026 adjusted EBITDA guidance of $266M-$308M vs. OPCO/Street’s prior $321M/$315M, and revenue guidance of $2.47B-2.59B vs. OPCO/Street’s prior $2.59B/$2.59B.